Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Anomalies of the Proximal Tubule

  • - General Urology - Common Urological Problems - Medical Renal Disease
  • Jul 29, 2010
  • Comments
  • Viewed: 36249
Tags: | aminoaciduria | bicarbonate reabsorption | calcium reabsorption | congenital cystinuria |

Defects of Amino Acid Reabsorption
A. Congenital Cystinuria
Increased excretion of cystine results in the formation of cystine calculi in the urinary tract.  Ornithine,  arginine, and lysine are also excreted in abnormally large quantities.

There is also a defect in absorption of these amino acids in the jejunum.  Nonopaque stones should be examined chemically to provide a specific diagnosis.

Treatment goals include a large fluid intake and keeping the urine pH above 7 by giving sodium bicarbonate and sodium citrate plus acetazolamide at bedtime to ensure an alkaline night urine. In refractory cases, a low-methionine (cystine precursor) diet may be necessary. Penicillamine has proved useful in some cases.

B. Aminoaciduria
Many amino acids may be poorly absorbed, resulting in unusual losses.  Failure to thrive and the presence of other tubular deficits suggest the diagnosis. There is no treatment.

Diagnosis of Medical Renal Disease

Medical Renal Disease

C. Hepatolenticular Degeneration (Wilson’s Disease)
In this congenital familial disease, aminoaciduria and renal tubular acidosis (RTA) are associated with cirrhosis of the liver and neurologic manifestations.  Hepatomegaly,  evidence of impaired liver function, spasticity, athetosis, emotional disturbances, and Kayser-Fleischer rings around the cornea constitute a unique syndrome. There is a decrease in synthesis of ceruloplasmin, with a deficit of plasma ceruloplasmin and an increase in free copper that may be etiologically specific.

Penicillamine is given to chelate and remove excess copper. Edathamil (EDTA) may also be used to remove copper.

D. Multiple Defects of Tubular Function (De Toni-Fanconi-Debré Syndrome)
Aminoaciduria,  phosphaturia,  glycosuria,  and a variable degree of RTA characterize this syndrome. Osteomalacia is a prominent clinical feature; other clinical and laboratory manifestations are associated with specific tubular defects described previously.

Treatment consists of replacing cation deficits (especially potassium),  correcting acidosis with bicarbonate or citrate, replacing phosphate loss with isoionic neutral phosphate (mono- and disodium salts) solution, and ensuring a liberal calcium intake. Vitamin D is useful, but the dose must be controlled by monitoring levels of serum calcium and phosphate.

E. Defects of Phosphorus & Calcium Reabsorption
Several sporadic, genetically transmitted, and acquired disorders are grouped under this category and are characterized by persisting hypophosphatemia because of excessive phosphaturia and an associated metabolic bone disorder, rickets in childhood,  and osteomalacia in adulthood.

Response to vitamin D therapy (1,25,-dihydroxycholecalciferol, the active analog of vitamin D) is variable.

F. Defects of Glucose Assorption (Renal Glycosuria)
Renal glycosuria results from an abnormally poor ability to reabsorb glucose and is present when blood glucose levels are normal. Ketosis is not present. The glucose tolerance response is normal. There is no treatment for renal glycosuria, just reassurance.

G. Defects of Bicarbonate Reabsorption
Proximal RTA,  type II,  is due to reduced bicarbonate reclamation in the proximal tubule, with resultant loss of bicarbonate in the urine and decreased bicarbonate concentration in extracellular fluid.  There are increased K+ losses into the urine and retrieval of Cl-  instead of HCO3. The acidosis is therefore associated with hypokalemia and hyperchloremia. Transport of glucose, amino acids,  phosphate,  and urate may be deficient as well (Fanconi syndrome).

Flavio G. Vincenti, MD, & William J.C. Amend, Jr., MD


  1. Adler S: Diabetic nephropathy: Linking histology, cell biology, and genetics. Kidney Int 2004;66:2095.
  2. Alric L et al: Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis 2004;43:617.
  3. Appel GB et al: Membranoproliferative glomerulonephritis Type II (dense deposit disease): An update. J Amer Soc Neph 2005;16: 1392.
  4. Barratt J, Feehally J: IgA nephropathy. J Amer Soc Neph 2005;16: 2088.
  5. Braden GL et al: Tubulointerstitial diseases. Am J Kidney Dis 2005; 46:560.
  6. Buhaescu I et al: Systemic vasculitis: Still a challenging disease. Am J Kidney Dis 2005;46:173.
  7. Chesney R: The changing face of childhood nephrotic syndrome. Kidney Int 2004;66:1294.
  8. Flanc RS et al: Treatment of diffuse proliferative lupus nephritis: A meta-analysis of randomized controlled trials. Am J Kidney Dis 2004;43:197.
  9. Couser WG (guest editor): Frontiers in nephrology: Membranous nephropathy. J Amer Soc Neph 2005;16:1184.
  10. Ginzler EM et al: Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005;353:2219.
  11. Grantham JJ: Advancement in the understanding of polycystic kidney disease: A system approach. Kidney Int 2003;64: 1154.
  12. Heering P et al: Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis 2004;43:10.
  13. Hruska KA: Treatment of chronic tubulointerstitial disease: A new concept. Kidney Int 2002;61:1911.
  14. Imaging the Kidney-Radiologic Imaging 2006. (Excerpts) Nephron Clin Pract 2006;103:c19.
  15. Izzedine H et al: Oculorenal manifestations in systemic autoimmune diseases. Am J Kidney Dis 2004;43:209.
  16. Javaid B, Quigg RJ: Treatment of glomerulonephritis: Will we ever have options other than steroids and cytotoxics? Kidney Int 2005;67:1692.
  17. Nair R, Walker PD: Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int 2006;69:1455.
  18. Noris M, Remuzzi G: Hemolytic uremic syndrome. J Amer Soc Neph 2005;16:1035.
  19. Perna A et al: Immunosuppressive treatment for idiopathic membranous nephropathy: A systematic review. Am J Kidney Disease 2004;44:385.
  20. Rosner MH, Bolton WK: Renal function testing. Am J Kidney Dis 2006;47:174.
  21. Rossert J: Drug-induced acute interstitial nephritis. Kidney Int 2001; 60:804.
  22. Tenenhouse HS, Murer H: Disorders of renal tubular phosphate transport. J Am Soc Neph 2003;14:240.
  23. Troyanov S et al: Renal pathology in idiopathic membranous nephropathy: A new perspective. Kidney Int 2006;69:1641.
  24. Wilmer WA et al: Management of glomerular proteinuria: A commentary. J Amer Soc Neph 2003;14:3217.

Bookmark and Share

Post a comment [ + Comment here + ]

There are no comments for this entry yet. [ + Comment here + ]

Your details

* Required field

Please enter the word you see in the image below:

Comments are moderated by our editors, so there may be a delay between submission and publication of your comment. Offensive or abusive comments will not be published.

metastatic cancer1 - slow prostate growth1 - kidney stones16 - pyelotomy1 - nephritis1 - prostate cancer screening7 - university of british columbia1 - lethal prostate cancer1 - differential diagnosis1 - pelvic diaphragm1 - abdominopelvic cavity1 - jcem1 - journal nature1 - urethral discharge2 - androgenic stimulation1 - invasive urologic surgery1 - serenoa1 - bladder discomfort1 - obesity complications1 - menopause1 - urethra3 - kidney transplant15 - kidney5 - imrt2 - proteins ralb1 - leak-point pressure4 - higher blood pressure1 - risk factors1 - kidney donor profile index1 - jama1 -